Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial. - Xia, Zhongjun; Leng, Yun; Fang, Baijun; Liang, Yang; Li, Wei; Fu, Chengcheng; Yang, Linhua; Ke, Xiaoyan; Jiang, Hua; Weng, Jianyu; Liu, Li; Zhao, Yaozhong; et al. (BMC Cancer, 2023)